This is the authors' abstract. We don't add key points for this paper.
Sepsis-induced immunoparalysis is a dynamic state of acquired immune dysfunction characterized by impaired antigen presentation, lymphocyte exhaustion, defective innate immune responses, and increased susceptibility to secondary infection. Increasing evidence suggests that mitochondrial dysfunction is a key metabolic mechanism underlying this immune failure. Rather than acting as a uniform injury signal, mitochondrial abnormalities affect immune-cell subsets in distinct ways: monocytes and macrophages lose antigen-presenting capacity, neutrophils develop impaired migration and antimicrobial activity, T cells acquire exhaustion-like phenotypes, and NK and B-cell responses become functionally constrained. This review summarizes how core mitochondrial processes, including bioenergetic failure, redox imbalance, mitochondrial danger-signal release, and defective quality control, contribute to sepsis-induced immunoparalysis. We further discuss how mitochondria-related readouts may complement established immune markers such as monocyte HLA-DR, lymphocyte count, PD-1/PD-L1, CD86, and IL-10 for patient stratification. Finally, we highlight therapeutic opportunities aimed at restoring mitochondrial fitness and immune competence in biomarker-defined septic patients.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: